Ifars Pharmaceutical Laboratories

Established in 1974, Ifars Pharmaceutical Laboratories is a prominent Indonesian pharmaceutical manufacturing company. Based in Jawa Tengah, Indonesia, the company is dedicated to producing high-quality, affordable medicines to meet the health needs of its clients. With a singular operational location, Ifars has built a reputation for reliability within the healthcare sector. The company's commitment extends beyond manufacturing to ensuring the safety and efficacy of its pharmaceutical products through rigorous pharmacovigilance practices.

Operating with a workforce of 500-1,000 employees, Ifars Pharmaceutical Laboratories generates an annual revenue of $42.2M. Their product portfolio includes a range of essential medications such as DEVOSIX Drops, FINAZIDE Tablets, VALENIX Gel, and BAXIDERM Salep, catering to diverse therapeutic areas. The company's operational focus is on maintaining stringent quality control throughout the production lifecycle. To understand the driving force behind their operations and commitment to excellence, you can Meet Ifars Pharmaceutical Laboratories's team.

As a key player in the Indonesian pharmaceutical and healthcare industries, Ifars Pharmaceutical Laboratories strives to be a recognized and trusted name. Their strategic focus on affordability and quality positions them to serve a broad market segment. The company leverages its established manufacturing capabilities and commitment to pharmacovigilance to ensure product integrity and patient safety. By consistently delivering essential medicines, Ifars contributes significantly to public health initiatives within the region.